查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
美國生物製藥第三方物流市場規模、份額和趨勢分析報告：按供應鏈（冷鏈、非冷鏈）、服務、產品類型（專業製藥）、細分市場預測，2022-2030 年
市場調查報告書
商品編碼
1170868

美國生物製藥第三方物流市場規模、份額和趨勢分析報告：按供應鏈（冷鏈、非冷鏈）、服務、產品類型（專業製藥）、細分市場預測，2022-2030 年

U.S. Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service, By Product Type (Specialty Drug), And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 78 Pages | 商品交期: 2-10個工作天內

價格

美國生物醫藥第三方物流市場的發展與趨勢

根據 Grand View Research, Inc. 的最新報告，美國生物製藥第三方物流市場規模預計到 2030 年將達到 872 億美元，預測期內復合年增長率為 7.3%。 對新型生物製劑不斷增長的需求和管理它們的需求正在推動市場增長。 推動增長的其他因素包括對跨不同地區運輸生物製品的溫控物流服務的需求不斷增加，以及分銷網絡的擴張以促進生物製藥公司的銷售。

由於航空運輸能力下降以及倉庫和機場勞動力減少，COVID-19 大流行對全球物流產生了一定程度的重大影響。 物流服務也受到地方政府暫停物流基礎設施、實施行動限制和製定額外要求以遏制病毒傳播的決定的影響。 結果，許多供應業務受到很大阻礙。

隨著與運輸和就地避難義務相關的政府法規的消退，美國生物製藥第三方物流行業的未來可能是有利的。 大流行期間觀察到對冷鏈物流的需求激增。 到 2021 年，我們預計 COVID-19 疫苗的生產和分銷將會增長。 例如，2021 年 3 月，聯邦快遞開始為 McKesson Corp. 向美國各地的中心運送 COVID-19 疫苗，自 2020 年 12 月中旬以來，該公司已經運送了數百萬支 COVID-19 疫苗。我在這裡。

美國生物醫藥第三方物流市場亮點

非冷鏈物流佔比最大，為80.2%，因為銷售的醫藥產品很多不需要溫控。

在對細胞療法、疫苗和檢測試劑盒等生物製劑需求的推動下，冷鏈物流行業預計在預測期內實現 10.1% 的最快複合年增長率。

對 COVID-19 疫苗不斷增長的需求是市場增長的主要驅動力。 此外，物流服務外包的增長趨勢也推動了增長。

隨著倉儲需求的增加，倉儲業獲得最大的市場份額，達到 43.4%

2021 年，由於專科藥的強勁增長，專科藥以 39.2% 的最大份額佔據市場主導地位。

內容

第一章調查方法及範圍

  • 市場細分和範圍
    • 供應鏈
    • 服務類型
    • 產品類型
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查的詳細信息
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細信息
    • 商品流分析（模型 1）
    • 批量價格分析（模型 2）
  • 二級信息列表
  • 主要信息列表
  • 縮寫列表
  • 目的

第 2 章執行摘要

  • 市場展望

第三章市場定義

  • 按供應鏈
  • 按服務類型
  • 產品類型

第 4 章美國生物製藥第三方物流市場：變量、趨勢和範圍

  • 市場細分和範圍
  • 市場驅動因素分析
    • 物流技術進步
    • 擴大逆向物流在生物製藥行業的應用
    • 對冷鏈物流的需求不斷增長
  • 市場製約因素分析
    • 外包期間的合規問題
  • 描繪滲透率和增長前景
  • 波特的五力分析
  • PESTEL 分析
  • Covid 影響和改革分析

第 5 章有關 Hub 服務、共付額和依從性的定性信息

  • 中心服務
  • 自費
  • 合規

第六章美國生物製藥第三方物流市場：供應鏈環節分析

  • 美國生物製藥第三方物流市場：2021 年和 2030 年市場份額分析
  • 冷鏈物流
  • 非冷鏈物流

第 7 章美國生物製藥第三方物流市場：服務類型細分分析

  • 美國生物製藥第三方物流市場：2021 年和 2030 年市場份額分析
  • 交通
    • 空運
    • 海運
    • 地面交通
  • 倉庫和倉儲
  • 其他服務

第 8 章美國生物製藥第三方物流市場：產品類型細分分析

  • 美國生物製藥第三方物流市場：2021 年和 2030 年市場份額分析
  • 特殊藥物
  • 通用的
  • 血漿衍生產品
  • 其他

第九章公司簡介

  • 公司簡介
    • FedEx
      • 公司簡介
      • 財務業績
      • 產品基準
    • DHL International GmbH
      • 公司簡介
      • 財務業績
      • 產品基準
    • SF Express
      • 公司簡介
      • 財務業績
      • 產品基準
    • United Parcel Service of America, Inc.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • AmerisourceBergen Corporation
      • 公司簡介
      • 財務業績
      • 產品基準
    • DB Schenker
      • 公司簡介
      • 財務業績
      • 產品基準
    • KUEHNE+NAGEL
      • 公司簡介
      • 財務業績
      • 產品基準
    • Kerry Logistics Network Limited
      • 公司簡介
      • 財務業績
      • 產品基準
    • Agility
      • 公司簡介
      • 財務業績
      • 產品基準
Product Code: GVR-4-68038-381-2

U.S. Biopharmaceutical Third-party Logistics Market Growth & Trends:

The U.S. biopharmaceutical third-party logistics market size is expected to reach USD 87.2 billion by 2030, expanding at a CAGR of 7.3% over the forecast period, according to a new report by Grand View Research, Inc. Increasing demand for novel biologics and the need to manage those is boosting the market growth. Besides, rising demand for temperature-controlled logistic services to transport biologics in various regions and growing distribution networks of biopharmaceutical companies to improve their sales are factors driving the growth.

The COVID-19 pandemic has had a major impact on global logistics to some extent due to diminished air freight capacity and reduced workforce at warehouses and airports. The decisions of local authorities to shut down the logistic infrastructure, enforce movement restrictions, or put in place additional requirements to suppress transmission of the virus have also impacted the logistic services. This has significantly hindered many supply operations.

The future seems lucrative for the biopharmaceutical third-party logistics industry in the U.S. with the retraction of government regulations related to transportation and shelter-in-place mandates. A sudden surge in the demand for cold chain logistics was observed during the pandemic. Growth in the manufacture and distribution of the COVID-19 vaccine is expected throughout 2021. For instance, in March 2021, FedEx Express started shipping COVID-19 vaccines for McKesson Corp. to centers all across the U.S. The company has already shipped millions of COVID-19 vaccines since mid-December 2020.

U.S. Biopharmaceutical Third-party Logistics Market Highlights:

  • Non-cold chain logistics held the largest market share of 80.2% owing to the sales of a large number of drugs that do not require any temperature control
  • The cold chain logistics segment is projected to witness the fastest CAGR of 10.1% over the forecast period owing to the demand for biologics, such as cellular therapies, vaccines, and test kits
  • The increasing demand for the COVID-19 vaccine is a major contributor to the market growth. Furthermore, the rising trend of outsourcing logistics services is also fueling the growth
  • Warehousing and storage held the largest market share of 43.4% share due to the growing demand for storage
  • Specialty drugs dominated the market with the largest share of 39.2% in 2021 due to substantial growth in specialty pharma

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Supply Chain
    • 1.1.2 Services Type
    • 1.1.3 Product Type
    • 1.1.4 Regional Scope
    • 1.1.5 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR'S Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.2 Volume Price Analysis (Model 2)
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective - 1
    • 1.10.2 Objective - 2
    • 1.10.3 Objective - 3
    • 1.10.4 Objective - 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Market Definition

    • 3.1.1 By Supply Chain
    • 3.1.2 By Services Type
    • 3.1.3 By Product type

Chapter 4 U.S. Biopharmaceutical Third-party Logistics Market: Variables, Trends, & Scope

  • 4.1 Market Segmentation and Scope
  • 4.2 Market Driver Analysis
    • 4.2.1 Technological advancements in logistics
    • 4.2.2 Growing applications of reverse logistics in the biopharmaceutical industry
    • 4.2.3 Rising demand for cold chain logistics
  • 4.3 Market Restraint Analysis
    • 4.3.1 Compliance Issues While Outsourcing
  • 4.4 Penetration & Growth Prospect Mapping
  • 4.5 Porter's Five Forces Analysis
  • 4.6 PESTEL Analysis
  • 4.7 Covid Impact and Reformation Analysis

Chapter 5 Qualitative Information for Hub Services, Copay, and Adherence

  • 5.1 Hub Services
  • 5.2 Copay
  • 5.3 Adherence

Chapter 6 U.S. Biopharmaceutical Third-party Logistics Market: Supply Chain Segment Analysis

  • 6.1 U.S. Biopharmaceutical Third-party Logistics Market: Market Share Analysis, 2021 & 2030
  • 6.2 Cold Chain Logistics
    • 6.2.1 Cold Chain Logistics market, 2018 - 2030 (USD Billion)
  • 6.3 Non-cold Chain Logistics
    • 6.3.1 Non-cold Chain Logistics market, 2018 - 2030 (USD Billion)

Chapter 7 U.S. Biopharmaceutical Third-party Logistics Market: Services Type Segment Analysis

  • 7.1 U.S. Biopharmaceutical Third-party Logistics Market: Market Share Analysis, 2021 & 2030
  • 7.2 Transportation
    • 7.2.1 Transportation market, 2018 - 2030 (USD Billion)
    • 7.2.2 Air freight
      • 7.2.2.1 Air freight market, 2018 - 2030 (USD Billion)
    • 7.2.3 Sea freight
      • 7.2.3.1 Sea freight market, 2018 - 2030 (USD Billion)
    • 7.2.4 Overland transportation
      • 7.2.4.1 Overland transportation market, 2018 - 2030 (USD Billion)
  • 7.3 Warehousing and Storage
    • 7.3.1 Warehousing and Storage market, 2018 - 2030 (USD Billion)
  • 7.4 Other Services
    • 7.4.1 Other Services market, 2018 - 2030 (USD Billion)

Chapter 8 U.S. Biopharmaceutical Third-party Logistics Market: Product Type Segment Analysis

  • 8.1 U.S. Biopharmaceutical Third-party Logistics Market: Market Share Analysis, 2021 & 2030
  • 8.2 Specialty Drugs
    • 8.2.1 Specialty Drugs market, 2018 - 2030 (USD Billion)
  • 8.3 Generics
    • 8.3.1 Generics market, 2018 - 2030 (USD Billion)
  • 8.4 Plasma-Derived Products
    • 8.4.1 Plasma Derived Products market, 2018 - 2030 (USD Billion)
  • 8.5 Others
    • 8.5.1 Others market, 2018 - 2030 (USD Billion)

Chapter 9 Company Profiles

  • 9.1 Company Profiles
    • 9.1.1 FedEx
      • 9.1.1.1 Company overview
      • 9.1.1.2 Financial performance
      • 9.1.1.3 Product benchmarking
    • 9.1.2 DHL International GmbH
      • 9.1.2.1 Company overview
      • 9.1.2.2 Financial performance
      • 9.1.2.3 Product benchmarking
    • 9.1.3 SF Express
      • 9.1.3.1 Company overview
      • 9.1.3.2 Financial performance
      • 9.1.3.3 Product benchmarking
    • 9.1.4 United Parcel Service of America, Inc.
      • 9.1.4.1 Company overview
      • 9.1.4.2 Financial performance
      • 9.1.4.3 Product benchmarking
      • 9.1.4.4 Strategic initiatives
    • 9.1.5 AmerisourceBergen Corporation
      • 9.1.5.1 Company overview
      • 9.1.5.2 Financial performance
      • 9.1.5.3 Product benchmarking
    • 9.1.6 DB Schenker
      • 9.1.6.1 Company overview
      • 9.1.6.2 Financial performance
      • 9.1.6.3 Product benchmarking
    • 9.1.7 KUEHNE + NAGEL
      • 9.1.7.1 Company overview
      • 9.1.7.2 Financial performance
      • 9.1.7.3 Product benchmarking
    • 9.1.8 Kerry Logistics Network Limited
      • 9.1.8.1 Company overview
      • 9.1.8.2 Financial performance
      • 9.1.8.3 Product benchmarking
    • 9.1.9 Agility
      • 9.1.9.1 Company overview
      • 9.1.9.2 Financial performance
      • 9.1.9.3 Product benchmarking

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. Biopharmaceutical Third-party Logistics Market, By Supply Chain, 2018 -2030 (USD Billion)
  • Table 4 U.S. Biopharmaceutical Third-party Logistics Market, By Service Type, 2018 -2030 (USD Billion)
  • Table 5 U.S. Biopharmaceutical Third-party Logistics Market, By Transportation, 2018 -2030 (USD Billion)
  • Table 6 U.S. Biopharmaceutical Third-party Logistics Market, By Product Type, 2018 -2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Volume Price Analysis
  • Fig. 10 U.S. Biopharmaceutical Third-party Logistics market snapshot (2020)
  • Fig. 11 U.S. Biopharmaceutical Third-party Logistics market segmentation
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 Penetration & growth prospect mapping
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 17 Reasons for non-adherence in the U.S.
  • Fig. 18 U.S. Biopharmaceutical Third-party Logistics market supply chain outlook: Segment dashboard
  • Fig. 19 U.S. Biopharmaceutical Third-party Logistics market: Supply chain movement analysis
  • Fig. 20 Cold chain logistics market, 2018 - 2030 (USD Billion)
  • Fig. 21 Non-cold chain logistics market, 2018 - 2030 (USD Billion)
  • Fig. 22 U.S. Biopharmaceutical Third-party Logistics market services type outlook: Segment dashboard
  • Fig. 23 U.S. Biopharmaceutical Third-party Logistics market: Services Type movement analysis
  • Fig. 24 Transportation market, 2018 - 2030 (USD Billion)
  • Fig. 25 Air freight market, 2018 - 2030 (USD Billion)
  • Fig. 26 Sea freight market, 2018 - 2030 (USD Billion)
  • Fig. 27 Overland transportation market, 2018 - 2030 (USD Billion)
  • Fig. 28 Warehousing and storage market, 2018 - 2030 (USD Billion)
  • Fig. 29 Other services market, 2018 - 2030 (USD Billion)
  • Fig. 30 U.S. Biopharmaceutical Third-party Logistics market product type outlook: Segment dashboard
  • Fig. 31 U.S. Biopharmaceutical Third-party Logistics market: Product type movement analysis
  • Fig. 32 Specialty drugs market, 2018 - 2030 (USD Billion)
  • Fig. 33 Generics market, 2018 - 2030 (USD Billion)
  • Fig. 34 Plasma-derived products market, 2018 - 2030 (USD Billion)
  • Fig. 35 Others market, 2018 - 2030 (USD Billion)